References
- Berner ES. Clinical decision support systems. Vol. 233. New York: Springer Science+ Business Media, LLC; 2007.
- Yu K-H, Beam AL, Kohane IS. Artificial intelligence in healthcare. Nat Biomed Eng. 2018;2(10):719–731. doi: 10.1038/s41551-018-0305-z
- Bajgain B, Lorenzetti D, Lee J, et al. Determinants of implementing artificial intelligence-based clinical decision support tools in healthcare: a scoping review protocol. BMJ Open. 2023;13(2):e068373. doi: 10.1136/bmjopen-2022-068373
- Sutton RT, Pincock D, Baumgart DC, et al. An overview of clinical decision support systems: benefits, risks, and strategies for success. npj Digital Med. 2020;3(1):17. doi: 10.1038/s41746-020-0221-y
- Damiani G, Pinnarelli L, Colosimo SC, et al. The effectiveness of computerized clinical guidelines in the process of care: a systematic review. BMC Health Serv Res. 2010;10(1):1–11. doi: 10.1186/1472-6963-10-2
- Choudhury A, Asan O. Role of artificial intelligence in patient safety outcomes: systematic literature review. JMIR Med Inform. 2020;8(7):e18599. doi: 10.2196/18599
- Armando LG, Miglio G, de Cosmo P, et al. Clinical decision support systems to improve drug prescription and therapy optimisation in clinical practice: a scoping review. BMJ Health Care Inform. 2023 May;30(1):e100683. doi: 10.1136/bmjhci-2022-100683
- Panagiotou OA, Contopoulos-Ioannidis DG, Papanikolaou PN, et al. Different black box warning labeling for same-class drugs. J Gen Intern Med. 2011 Jun;26(6):603–610.
- Schick A, Miller KL, Lanthier M, et al. Evaluation of pre-marketing factors to predict post-marketing boxed warnings and safety withdrawals. Drug Saf. 2017 Jun;40(6):497–503.
- Drug Safety-related Labeling Changes (SrLC) [Internet]. 2023. Available from: https://www.accessdata.fda.gov/scripts/cder/safetylabelingchanges/
- FDA. Subscribe to MedWatch Safety Alerts. 2023. Available from: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program/subscribe-medwatch-safety-alerts
- List of medicines under additional monitoring [Internet]. EMA website; 2023. Available from: https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/medicines-under-additional-monitoring/list-medicines-under-additional-monitoring
- FDA. Risk evaluation and mitigation strategies | REMS. 2023. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/risk-evaluation-and-mitigation-strategies-rems
- Approved risk evaluation and mitigation strategies (REMS) [Internet]. 2023. Available from: https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm
- EMA. Risk management plans. 2023. Available from: https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/pharmacovigilance/risk-management/risk-management-plans#guidance-on-rmp-format-section
- Lyell D, Coiera E. Automation bias and verification complexity: a systematic review. J Am Med Inf Assoc. 2016;24(2):423–431. doi: 10.1093/jamia/ocw105
- Lyell D, Coiera E. Automation bias and verification complexity: a systematic review. J Am Med Inform Assoc. 2017 Mar 1;24(2):423–431. doi: 10.1093/jamia/ocw105
- FDA. Software as a medical device (SAMD): clinical evaluation. In: Health C, editor. FDA website. Maryland, USA: FDA; 2018. p. 201.
- FDA. Clinical decision support software. Health CfDaR, Research CfBEa, Research CfDEa, editors. Maryland, USA: FDA; 2022. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software
- FDA. Artificial Intelligence and Machine Learning (AI/ML)-enabled medical devices. Maryland, USA: FDA; 2023.
- Consolidated text: Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance)Text with EEA relevance, 2017/745. 2023.
- Consolidated text: Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU 2017/746. 2023.
- The medical devices regulations 2002, 2002-618. 2002.
- MHRA. In-house manufacture of medical devices in Great Britain. London: Medicines and Healthcare Products Regulatory Agency; 2020.
- FDA. Predetermined change control plans for machine learning-enabled medical devices: guiding principles. Maryland USA: FDA; 2023. https://www.fda.gov/medical-devices/software-medical-device-samd/predetermined-change-control-plans-machine-learning-enabled-medical-devices-guiding-principles
- Stöger K, Schneeberger D, Holzinger A. Medical artificial intelligence: the European legal perspective. Commun ACM. 2021;64(11):34–36.
- Müller H, Holzinger A, Plass M, et al. Explainability and causability for artificial intelligence-supported medical image analysis in the context of the European in vitro diagnostic regulation. New Biotechnology. 2022;70:67–72. doi: 10.1016/j.nbt.2022.05.002